SWK Holdings

Oct 23, 2023 | outsourcedpharma.com | Peter Alexander |Phillip Ramsey |Jody Staggs |SWK Holdings |Louis Garguilo

We’ve all heard how important speed, time to milestone, and quality are when choosing a CTDMO. Our “Why choosing a client-centric CTDMO is critical when outsourcing biomanufacturing projects” infographic details the top five considerations and the complexities biopharma companies such as yours consider when selecting a CTDMO. Evaluate the infographic against your current challenges and share with us. We’re here. We’re built to serve. Download infographic.

Sep 28, 2023 | advfn.com | SWK Holdings |ized Signatory

As filed with the Securities and Exchange Commission on September 28, 2023 Registration No. 333-274511 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT No. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SWK HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) Delaware 6159 77-0435679 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S....

Sep 27, 2023 | lifescienceleader.com | Jody Staggs |SWK Holdings

By Jody Staggs, president and CEO, SWK Holdings Small life science companies are the driving force behind groundbreaking medical innovations that have the potential to transform lives. Yet in a market with strong headwinds, securing financing has emerged as a central challenge. A sector once flush with cash is facing a liquidity crunch as the COVID-19 pandemic recedes from memory and capital markets are more discerning in funding the sector.

Sep 27, 2023 | outsourcedpharma.com | Jody Staggs |SWK Holdings |Louis Garguilo

Guest Column | September 27, 2023 By Jody Staggs, president and CEO, SWK Holdings Small life science companies are the driving force behind groundbreaking medical innovations that have the potential to transform lives. Yet in a market with strong headwinds, securing financing has emerged as a central challenge.

Jun 7, 2023 | outsourcedpharma.com | Jody Staggs |SWK Holdings |Louis Garguilo

Get more pharma outsourcing insight with our FREE newsletter sign me up Development Contract Manufacturing Packaging Logistics Market Research Guest Column | June 7, 2023 By Jody Staggs, SWK Holdings Rising interest rates have created challenges for life sciences companies seeking funding.